These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 1382424

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effect of valproic acid, its unsaturated metabolites and some structurally related fatty acids on the binding of warfarin and dansylsarcosine to human albumin.
    Panjehshahin MR, Bowmer CJ, Yates MS.
    Biochem Pharmacol; 1991 Apr 15; 41(8):1227-33. PubMed ID: 1706921
    [Abstract] [Full Text] [Related]

  • 4. Binding sites of fluorescent probes on human serum albumin.
    Muller N, Lapicque F, Drelon E, Netter P.
    J Pharm Pharmacol; 1994 Apr 15; 46(4):300-4. PubMed ID: 7519671
    [Abstract] [Full Text] [Related]

  • 5. Monoacylglycerol binding to human serum albumin: evidence that monooleoylglycerol binds at the dansylsarcosine site.
    Thumser AE, Buckland AG, Wilton DC.
    J Lipid Res; 1998 May 15; 39(5):1033-8. PubMed ID: 9610770
    [Abstract] [Full Text] [Related]

  • 6. Species differences of serum albumins: I. Drug binding sites.
    Kosa T, Maruyama T, Otagiri M.
    Pharm Res; 1997 Nov 15; 14(11):1607-12. PubMed ID: 9434282
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Kinetics of drug binding to human serum albumin: allosteric and competitive inhibition at the benzodiazepine binding site by free fatty acids of various chain lengths.
    Menke G, Wörner W, Kratzer W, Rietbrock N.
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Nov 15; 339(1-2):42-7. PubMed ID: 2471088
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Human serum albumin binding assay based on displacement of a non selective fluorescent inhibitor.
    Thorarensen A, Sarver RW, Tian F, Ho A, Romero DL, Marotti KR.
    Bioorg Med Chem Lett; 2007 Aug 15; 17(16):4646-9. PubMed ID: 17560104
    [Abstract] [Full Text] [Related]

  • 12. Structure of pressure-induced denatured state of human serum albumin: a comparison with the intermediate in urea-induced denaturation.
    Tanaka N, Nishizawa H, Kunugi S.
    Biochim Biophys Acta; 1997 Mar 07; 1338(1):13-20. PubMed ID: 9074611
    [Abstract] [Full Text] [Related]

  • 13. Binding of sulphamethazine to pig plasma proteins and albumin.
    Munsey T, Grigg RE, McCormack A, Symonds HW, Bowmer CJ.
    J Vet Pharmacol Ther; 1996 Apr 07; 19(2):135-41. PubMed ID: 8735422
    [Abstract] [Full Text] [Related]

  • 14. The effects of N-B transition of human serum albumin on the specific drug-binding sites.
    Wanwimolruk S, Birkett DJ.
    Biochim Biophys Acta; 1982 Dec 20; 709(2):247-55. PubMed ID: 6185151
    [Abstract] [Full Text] [Related]

  • 15. The Effect of Ethanol on the Hydrolysis of Ester-Type Drugs by Human Serum Albumin.
    Tatsumi A, Inoue S, Hamaguchi T, Iwakawa S.
    Biol Pharm Bull; 2018 Feb 01; 41(2):277-280. PubMed ID: 29176265
    [Abstract] [Full Text] [Related]

  • 16. Fluorescence energy transfer study of the relationship between the lone tryptophan residue and drug binding sites in human serum albumin.
    Kasai S, Horie T, Mizuma T, Awazu S.
    J Pharm Sci; 1987 May 01; 76(5):387-92. PubMed ID: 3656100
    [Abstract] [Full Text] [Related]

  • 17. Effects of nonenzymatic glycation and fatty acids on functional properties of human albumin.
    Lautenslager GT, Shearman CW, Hud E, Cohen MP.
    Metabolism; 2011 Dec 01; 60(12):1683-91. PubMed ID: 21632076
    [Abstract] [Full Text] [Related]

  • 18. A novel binding site for bile acids on human serum albumin.
    Takikawa H, Sugiyama Y, Hanano M, Kurita M, Yoshida H, Sugimoto T.
    Biochim Biophys Acta; 1987 Nov 06; 926(2):145-53. PubMed ID: 2444264
    [Abstract] [Full Text] [Related]

  • 19. Species-dependent stereoselective drug binding to albumin: a circular dichroism study.
    Pistolozzi M, Bertucci C.
    Chirality; 2008 Mar 06; 20(3-4):552-8. PubMed ID: 18172833
    [Abstract] [Full Text] [Related]

  • 20. Structural requirements for drug binding to site II on human serum albumin.
    Wanwimolruk S, Birkett DJ, Brooks PM.
    Mol Pharmacol; 1983 Nov 06; 24(3):458-63. PubMed ID: 6195516
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.